Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug
- PMID: 28666892
- PMCID: PMC5745300
- DOI: 10.1016/j.pbb.2017.06.015
Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug
Abstract
Drug addiction can be conceptualized as a disorder of maladaptive decision making in which drugs are chosen at the expense of pro-social, nondrug alternatives. The study of decision making in drug addiction has focused largely on the role of impulsivity as a facilitator of addiction, in particular the tendency for drug abusers to choose small, immediate gains over larger but delayed outcomes (i.e., delay discounting). A parallel line of work, also focused on decision making in drug addiction, has focused on identifying the determinants underlying the choice to take drugs over nondrug alternatives (i.e., drug vs. nondrug choice). Both tracks of research have been valuable tools in the development of pharmacotherapies for treating maladaptive decision making in drug addiction, and a number of common drugs have been studied in both designs. However, we have observed that there is little uniformity in the administration regimens of potential treatments between the designs, which hinders congruence in the development of single treatment strategies to reduce both impulsive behavior and drug choice. The current review provides an overview of the drugs that have been tested in both delay-discounting and drug-choice designs, and focuses on drugs that reduced the maladaptive choice in both designs. Suggestions to enhance congruence between the findings in future studies are provided. Finally, we propose the use of a hybridized, experimental approach that may enable researchers to test the effectiveness of therapeutics at decreasing impulsive and drug choice in a single design.
Published by Elsevier Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Aboujaoude E, Salame WO. Naltrexone: a pain-addiction treatment? CNS Drugs. 2016;30:719–733. - PubMed
-
- Acheson A, Reynolds B, Richards JB, de Wit H. Diazepam impairs behavioral inhibition but not delay discounting or risk taking in healthy adults. Exp Clin Psychopharmacol. 2006;14:190–198. - PubMed
-
- Adriani W, Zoratto F, Laviola G. Brain processes in discounting: consequences of adolescent methylphenidate exposure. Curr Top Behav Neurosci. 2012;9:113–143. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
